Cargando…
A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm
BACKGROUND AND OBJECTIVES: Whether chemotherapy is needed in node-negative triple-negative breast cancer (TNBC) patients with tumor size less than 1 cm is still controversial. In our research, we constructed a novel risk-scoring system to identify the potential TNBC patients benefiting from adjuvant...
Autores principales: | Li, Yijun, Ma, Rulan, Chen, Heyan, Pu, Shengyu, Xie, Peiling, He, Jianjun, Zhang, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260021/ https://www.ncbi.nlm.nih.gov/pubmed/35814418 http://dx.doi.org/10.3389/fonc.2022.788883 |
Ejemplares similares
-
Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based study
por: Pu, Shengyu, et al.
Publicado: (2023) -
Bioinformatics analysis for the role of CALR in human cancers
por: Li, Yijun, et al.
Publicado: (2021) -
A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database
por: Chen, Heyan, et al.
Publicado: (2023) -
The nodal positivity rate in breast pCR patients with initially, clinically node-negative breast cancer after neoadjuvant systemic therapy: A systematic review and meta-analysis
por: Ma, Le, et al.
Publicado: (2023) -
A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database
por: Li, Yijun, et al.
Publicado: (2020)